| HOME >> BIOLOGY >> TECHNOLOGY |
used in operating activities:
Depreciation and amortization 292 82
Stock based compensation expense 133 56
Stock options issued for services - 8
Changes in operating assets and liabilities:
Accounts receivable (77) 130
Inventory - 576
Other assets 134 52
Accounts payable (100) (2,936)
Accrued project costs 12 (547)
Payroll liabilities 168 812
Deferred income 26 -
Asset retirement obligation - 147
Interest payable (3) -
Net cash used in operating activities (4,288) (11,873)
Investing activities
Decreases (increases) of short-term investments 5,601 12,044
Purchases of investments - (500)
Realized loss on investments 392 -
Net cash provided by investing activities 5,993 11,544
Financing activities
Repayment of convertible notes (553) -
Cash restricted to restricted letters of credit - 297
Net cash (used in) provided by financing activities (553) 297
Increase (decrease) in cash and cash equivalents 1,152 (32)
Cash and cash equivalents at beginning of period 3,554 2,121
Cash and cash equivalents at end of period $4,70
'/>"/>
| SOURCE Insmed Inc. Copyright©2008 PR Newswire. All rights reserved |